, Volume 218, Issue 1, pp 69–82 | Cite as

Translational and reverse translational research on the role of stress in drug craving and relapse



Rationale and background

High relapse rates during abstinence are a pervasive problem in drug addiction treatment. Relapse is often associated with stress exposure, which can provoke a subjective state of drug craving that can also be demonstrated under controlled laboratory conditions. Stress-induced relapse and craving in humans can be modeled in mice, rats, and monkeys using a reinstatement model in which drug-taking behaviors are extinguished and then reinstated by acute exposure to certain stressors. Studies using the reinstatement model in rats have identified the role of several neurotransmitters and brain sites in stress-induced reinstatement of drug seeking, but the degree to which these preclinical findings are relevant to the human condition is largely unknown.

Objectives and highlights

Here, we address this topic by discussing recent results on the effect of alpha-2 adrenoceptors and substance P-NK1 receptor antagonists on stress-induced reinstatement in mice and rats and stress-induced craving and potentially stress-induced relapse in humans. We also discuss brain sites and circuits involved in stress-induced reinstatement of drug seeking in rats and those activated during stress-induced craving in humans.


There is evidence that alpha-2 adrenoceptor agonists and NK1 receptor antagonists decrease stress-induced drug seeking in rats and stress-induced craving in humans. Whether these drugs would also prevent stress-induced drug relapse in humans and whether similar or different brain mechanisms are involved in stress-induced reinstatement in non-humans and stress-induced drug craving and relapse in humans are subjects for future research.


Corticotropin-releasing factor Craving Extinction NK1 receptor Noradrenaline Reinstatement Relapse Reverse translational research Stress Substance P Translational research Yohimbine 


  1. Abercrombie ED, Keller RW Jr, Zigmond MJ (1988) Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience 27:897–904PubMedCrossRefGoogle Scholar
  2. Aghajanian GK, VanderMaelen CP (1982) Alpha 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science 215:1394–1396PubMedCrossRefGoogle Scholar
  3. Aguilar MA, Rodriguez-Arias M, Minarro J (2009) Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev 59:253–77PubMedCrossRefGoogle Scholar
  4. Ahmed SH, Walker JR, Koob GF (2000) Persistent increase in the motivation to take heroin in rats with history of drug escalation. Neuropsychopharmacology 22:413–421PubMedCrossRefGoogle Scholar
  5. Back SE, Hartwell K, DeSantis SM, Saladin M, McRae-Clark AL, Price KL, Moran-Santa Maria MM, Baker NL, Spratt E, Kreek MJ, Brady KT (2010) Reactivity to laboratory stress provocation predicts relapse to cocaine. Drug Alcohol Depend 106:21–27PubMedCrossRefGoogle Scholar
  6. Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC (2004) Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev 111:33–51PubMedCrossRefGoogle Scholar
  7. Bale TL (2006) Stress sensitivity and the development of affective disorders. Horm Behav 50:529–533PubMedCrossRefGoogle Scholar
  8. Ballard TM, Sanger S, Higgins GA (2001) Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonist. Eur J Pharmacol 412:255–264PubMedCrossRefGoogle Scholar
  9. Banna KM, Back SE, Do P, See RE (2010) Yohimbine stress potentiates conditioned cue-induced reinstatement of heroin-seeking in rats. Behav Brain Res 208:144–148PubMedCrossRefGoogle Scholar
  10. Barr CS, Dvoskin RL, Gupte M, Sommer W, Sun H, Schwandt ML, Lindell SG, Kasckow JW, Suomi SJ, Goldman D, Higley JD, Heilig M (2009) Functional CRH variation increases stress-induced alcohol consumption in primates. Proc Nat Acad Sci USA 106:14593–14598PubMedCrossRefGoogle Scholar
  11. Becker JB, Hu M (2008) Sex differences in drug abuse. Front Neuroendocrinol 29:36–47PubMedCrossRefGoogle Scholar
  12. Becker JB, Monteggia LM, Perrot-Sinal TS, Romeo RD, Taylor JR, Yehuda R, Bale TL (2007) Stress and disease: is being female a predisposing factor? J Neurosci 27:11851–11855PubMedCrossRefGoogle Scholar
  13. Binneman B, Feltner D, Kolluri S, Shi Y, Qiu R, Stiger T (2008) A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression. Am J Psychiatry 165:617–620PubMedCrossRefGoogle Scholar
  14. Blomeyer D, Treutlein J, Esser G, Schmidt MH, Schumann G, Laucht M (2008) Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use. Biol Psychiatry 63:146–151PubMedCrossRefGoogle Scholar
  15. Bossert JM, Ghitza UE, Lu L, Epstein DH, Shaham Y (2005) Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications. Eur J Pharmacol 526:36–50PubMedCrossRefGoogle Scholar
  16. Bouton ME, Swartzentruber D (1991) Sources of relapse after extinction in Pavlovian and instrumental learning. Clin Psychol Rev 11:123–140CrossRefGoogle Scholar
  17. Bremner JD, Krystal JH, Southwick SM, Charney DS (1996a) Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse 23:28–38PubMedCrossRefGoogle Scholar
  18. Bremner JD, Krystal JH, Southwick SM, Charney DS (1996b) Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse 23:39–51PubMedCrossRefGoogle Scholar
  19. Brown SA, Vik PW, McQuaid JR, Patterson TL, Irwin MR, Grant I (1990) Severity of psychosocial stress and outcome of alcoholism treatment. J Abnorm Psychol 99:344–348PubMedCrossRefGoogle Scholar
  20. Brown SA, Vik PW, Patterson TL, Grant I, Schuckit MA (1995) Stress, vulnerability and adult alcohol relapse. J Stud Alcohol 56:538–545PubMedGoogle Scholar
  21. Brown ZJ, Tribe E, D’Souza NA, Erb S (2009) Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat. Psychopharmacology 203:121–130PubMedCrossRefGoogle Scholar
  22. Brownell KD, Marlatt GA, Lichtenstein E, Wilson GT (1986) Understanding and preventing relapse. Am Psychol 41:765–782PubMedCrossRefGoogle Scholar
  23. Bruijnzeel AW, Prado M, Isaac S (2009) Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse. Biol Psychiatry 66:110–117PubMedCrossRefGoogle Scholar
  24. Buffalari DM, See RE (2011) Inactivation of the bed nucleus of the stria terminalis in an animal model of relapse: effects on conditioned cue-induced reinstatement and its enhancement by yohimbine. Psychopharmacology 213:19–27PubMedCrossRefGoogle Scholar
  25. Cannon WB (1935) Stresses and strains of homeostasis. Am J Med Sci 189:1–14CrossRefGoogle Scholar
  26. Capriles N, Rodaros D, Sorge RE, Stewart J (2003) A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats. Psychopharmacology 168:66–74PubMedCrossRefGoogle Scholar
  27. Carroll ME (1985) The role of food deprivation in the maintenance and reinstatement of cocaine-seeking behavior in rats. Drug Alcohol Depend 16:95–109PubMedCrossRefGoogle Scholar
  28. Carroll ME, Lynch WJ, Roth ME, Morgan AD, Cosgrove KP (2004) Sex and estrogen influence drug abuse. Trends Pharmacol Sci 25:273–279PubMedCrossRefGoogle Scholar
  29. Carter AJ (1997) Hippocampal noradrenaline release in awake, freely moving rats is regulated by alpha-2 adrenoceptors but not by adenosine receptors. J Pharmacol Exp Ther 281:648–654PubMedGoogle Scholar
  30. Chrousos GP, Gold PW (1992) The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267:1244–1452PubMedCrossRefGoogle Scholar
  31. Coffey SF, Saladin ME, Drobes DJ, Brady KT, Dansky BS, Kilpatrick DG (2002) Trauma and substance cue reactivity in individuals with comorbid posttraumatic stress disorder and cocaine or alcohol dependence. Drug Alcohol Depend 65:115–127PubMedCrossRefGoogle Scholar
  32. Cohen F, Horowitz MJ, Lazarus RS, Moos RH, Robbins LN, Rose RM, Rutter M (1982) Panel report on psychosocial and modifiers of stress. In: Eliott GR, Eisdorfer C (eds) Stress and human health. Springer, New York, pp 147–188Google Scholar
  33. Cohen S, Evans GW, Stokols D, Krantz DS (1986) Behavior, health, and environmental stress. Plenum Press, New YorkGoogle Scholar
  34. Conrad KL, McCutcheon JE, Cotterly LM, Ford KA, Beales M, Marinelli M (2010) Persistent increases in cocaine-seeking behavior after acute exposure to cold swim stress. Biol Psychiatry 68:303–305PubMedCrossRefGoogle Scholar
  35. Cooney NL, Litt MD, Cooney JL, Pilkey DT, Steinberg HR, Oncken CA (2007) Alcohol and tobacco cessation in alcohol-dependent smokers: analysis of real-time reports. Psychol Addict Behav 21:277–286PubMedCrossRefGoogle Scholar
  36. Dedovic K, Duchesne A, Andrews J, Engert V, Pruessner JC (2009) The brain and the stress axis: the neural correlates of cortisol regulation in response to stress. Neuroimage 47:864–871PubMedCrossRefGoogle Scholar
  37. Ebner K, Singewald N (2006) The role of substance P in stress and anxiety responses. Amino Acids 31:251–272PubMedCrossRefGoogle Scholar
  38. Ebner K, Singewald N (2007) Stress-induced release of substance P in the locus coeruleus modulates cortical noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol 376:73–82PubMedCrossRefGoogle Scholar
  39. Ebner K, Rupniak NM, Saria A, Singewald N (2004) Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats. Proc Natl Acad Sci USA 101:4280–4285PubMedCrossRefGoogle Scholar
  40. Ebner K, Singewald GM, Whittle N, Ferraguti F, Singewald N (2008) Neurokinin 1 receptor antagonism promotes active stress coping via enhanced septal 5-HT transmission. Neuropsychopharmacology 33:1929–1941PubMedCrossRefGoogle Scholar
  41. Elliott PJ (1988) Place aversion induced by the substance P analogue, dimethyl-C7, is not state dependent: implication of substance P in aversion. Exp Brain Res 73:354–356PubMedCrossRefGoogle Scholar
  42. Epstein DH, Preston KL (2003) The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology 168:31–41PubMedCrossRefGoogle Scholar
  43. Epstein DH, Preston KL, Stewart J, Shaham Y (2006) Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology 189:1–16PubMedCrossRefGoogle Scholar
  44. Epstein DH, Marrone GF, Heishman SJ, Schmittner J, Preston KL (2009a) Tobacco, cocaine, and heroin: craving and use during daily life. Addict Behav 35:318–324PubMedCrossRefGoogle Scholar
  45. Epstein DH, Willner-Reid J, Vahabzadeh M, Mezghanni M, Lin JL, Preston KL (2009b) Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. Arch Gen Psychiatry 66:88–94PubMedCrossRefGoogle Scholar
  46. Erb S (2010) Evaluation of the relationship between anxiety during withdrawal and stress-induced reinstatement of cocaine seeking. Prog Neuropsychopharmacol Biol Psychiatry 34:798–807PubMedCrossRefGoogle Scholar
  47. Erb S, Stewart J (1999) A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J Neurosci 19:RC35PubMedGoogle Scholar
  48. Erb S, Shaham Y, Stewart J (1996) Stress reinstates cocaine-seeking behavior after prolonged extinction and drug-free periods. Psychopharmacology 128:408–412PubMedCrossRefGoogle Scholar
  49. Erb S, Shaham Y, Stewart J (1998) The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci 18:5529–5536PubMedGoogle Scholar
  50. Erb S, Hitchcott PK, Rajabi H, Mueller D, Shaham Y, Stewart J (2000) Alpha-2 adrenergic agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 23:138–150PubMedCrossRefGoogle Scholar
  51. Erb S, Salmaso N, Rodaros D, Stewart J (2001a) A role for the CRF-containing pathway projecting from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology 158:360–365PubMedCrossRefGoogle Scholar
  52. Erb S, Shaham Y, Stewart J (2001b) Stress-induced relapse to drug seeking in the rat: role of the bed nucleus of the stria terminalis and amygdala. Stress 4:289–303CrossRefGoogle Scholar
  53. Erb S, Petrovic A, Yi D, Kayyali H (2006) Central injections of CRF reinstate cocaine seeking in rats after postinjection delays of up to 3 h: an influence of time and environmental context. Psychopharmacology 187:112–120PubMedCrossRefGoogle Scholar
  54. Euler US, Gaddum JH (1931) An unidentified depressor substance in certain tissue extracts. J Physiol 72:74Google Scholar
  55. Feltenstein MW, See RE (2006) Potentiation of cue-induced reinstatement of cocaine-seeking in rats by the anxiogenic drug yohimbine. Behav Brain Res 174:1–8PubMedCrossRefGoogle Scholar
  56. Feltenstein MW, Henderson AR, See RE (2011) Enhancement of cue-induced reinstatement of cocaine-seeking in rats by yohimbine: sex differences and the role of the estrous cycle. Psychopharmacology (in press)Google Scholar
  57. File SE (1997) Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test. Pharmacol Biochem Behav 58:747–752PubMedCrossRefGoogle Scholar
  58. Fox HC, Sinha R (2009) Sex differences in drug-related stress-system changes: implications for treatment in substance-abusing women. Harv Rev Psychiatry 17:103–119PubMedCrossRefGoogle Scholar
  59. Fox HC, Hong KI, Siedlarz KM, Bergquist K, Anderson G, Kreek MJ, Sinha R (2009) Sex-specific dissociations in autonomic and HPA responses to stress and cues in alcohol-dependent patients with cocaine abuse. Alcohol Alcohol 44:575–585PubMedGoogle Scholar
  60. Funk D, Harding S, Juzytsch W, Le AD (2005) Effects of unconditioned and conditioned social defeat on alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology 183:341–349PubMedCrossRefGoogle Scholar
  61. Funk CK, Zorrilla EP, Lee MJ, Rice KC, Koob GF (2007) Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry 61:78–86PubMedCrossRefGoogle Scholar
  62. Furmark T, Appel L, Michelgard A, Wahlstedt K, Ahs F, Zancan S, Jacobsson E, Flyckt K, Grohp M, Bergstrom M, Pich EM, Nilsson LG, Bani M, Langstrom B, Fredrikson M (2005) Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo. Biol Psychiatry 58:132–142PubMedCrossRefGoogle Scholar
  63. Gehlert DR, Cippitelli A, Thorsell A, Le AD, Hipskind PA, Hamdouchi C, Lu J, Hembre EJ, Cramer J, Song M, McKinzie D, Morin M, Ciccocioppo R, Heilig M (2007) 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl- imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J Neurosci 27:2718–2726PubMedCrossRefGoogle Scholar
  64. George O, Ghozland S, Azar MR, Cottone P, Zorrilla EP, Parsons LH, O’Dell LE, Richardson HN, Koob GF (2007) CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proc Natl Acad Sci USA 104:17198–17203PubMedCrossRefGoogle Scholar
  65. George DT, Gilman J, Hersh J, Thorsell A, Herion D, Geyer C, Peng X, Kielbasa W, Rawlings R, Brandt JE, Gehlert DR, Tauscher JT, Hunt SP, Hommer D, Heilig M (2008) Neurokinin 1 receptor antagonism as a possible therapy for alcoholism. Science 319:1536–1539PubMedCrossRefGoogle Scholar
  66. Georges F, Aston-Jones G (2001) Potent regulation of midbrain dopamine neurons by the bed nucleus of the stria terminalis. J Neurosci 21:RC160PubMedGoogle Scholar
  67. Georges F, Aston-Jones G (2002) Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J Neurosci 22:5173–5187PubMedGoogle Scholar
  68. Ghitza UE, Gray SM, Epstein DH, Rice KC, Shaham Y (2006) The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF(1) receptors. Neuropsychopharmacology 31:2188–2196PubMedGoogle Scholar
  69. Ghitza UE, Nair SG, Golden SA, Gray SM, Uejima JL, Bossert JM, Shaham Y (2007) Peptide YY3-36 decreases reinstatement of high-fat food seeking during dieting in a rat relapse model. J Neurosci 27:11522–11532PubMedCrossRefGoogle Scholar
  70. Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159:1642–1452PubMedCrossRefGoogle Scholar
  71. Goldstein JM, Jerram M, Abbs B, Whitfield-Gabrieli S, Makris N (2010) Sex differences in stress response circuitry activation dependent on female hormonal cycle. J Neurosci 30:431–438PubMedCrossRefGoogle Scholar
  72. Greenwell TN, Funk CK, Cottone P, Richardson HN, Chen SA, Rice KC, Zorrilla EP, Koob GF (2009) Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats. Addict Biol 14:130–143PubMedCrossRefGoogle Scholar
  73. Hall SM, Havassy BE, Wassermann DA (1990) Commitment to abstinence and acute stress in relapse to alcohol, opiates and nicotine. J Counsel Clin Psychol 58:175–181CrossRefGoogle Scholar
  74. Hansson AC, Cippitelli A, Sommer WH, Fedeli A, Bjork K, Soverchia L, Terasmaa A, Massi M, Heilig M, Ciccocioppo R (2006) Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci USA 103:15236–15241PubMedCrossRefGoogle Scholar
  75. Heilig M, Koob GF (2007) A key role for corticotropin-releasing factor in alcohol dependence. Trend Neurosci 30:399–406PubMedCrossRefGoogle Scholar
  76. Highfield D, Yap J, Grimm J, Shalev U, Shaham Y (2001) Repeated lofexidine treatment attenuates stress-induced, but not drug cues-induced reinstatement of a heroin-cocaine mixture (speedball) seeking in rats. Neuropsychopharmacology 25:320–331PubMedCrossRefGoogle Scholar
  77. Hunt WA, Barnett LW, Branch LG (1971) Relapse rates in addiction programs. J Clin Psychol 27:455–456PubMedCrossRefGoogle Scholar
  78. Hyman SM, Fox H, Hong KI, Doebrick C, Sinha R (2007) Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment. Exp Clin Psychopharmacol 15:134–143PubMedCrossRefGoogle Scholar
  79. Jobes ML, Ghitza UE, Epstein DH, Phillips KA, Heishman SJ, Preston KL (2011) Clonidine blocks stress-induced craving in cocaine users. Psychopharmacology (in press)Google Scholar
  80. Julius D (1976) NIDA’s naltrexone research program. NIDA Res Monogr 9:5–11PubMedGoogle Scholar
  81. Kalivas PW, McFarland K (2003) Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology 168:44–56PubMedCrossRefGoogle Scholar
  82. Katz JL, Higgins ST (2003) The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology 168:21–30PubMedCrossRefGoogle Scholar
  83. Keller M, Montgomery S, Ball W, Morrison M, Snavely D, Liu G, Hargreaves R, Hietala J, Lines C, Beebe K, Reines S (2006) Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol Psychiatry 59:216–223PubMedCrossRefGoogle Scholar
  84. Kippin TE, Fuchs RA, Mehta RH, Case JM, Parker MP, Bimonte-Nelson HA, See RE (2005) Potentiation of cocaine-primed reinstatement of drug seeking in female rats during estrus. Psychopharmacology 182:245–252PubMedCrossRefGoogle Scholar
  85. Kirschbaum C, Pirke KM, Hellhammer DH (1993) The ‘Trier Social Stress Test’—a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28:76–81PubMedCrossRefGoogle Scholar
  86. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams AR, Hewson L, Smith D, Carlson EJ, Hargreaves RJ, Rupniak NM (1998a) Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281:1640–1645PubMedCrossRefGoogle Scholar
  87. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams AR, Hewson L, Smith D, Rupniak NM (1998b) Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281:1640–1645PubMedCrossRefGoogle Scholar
  88. Kramer MS, Winokur A, Kelsey J, Preskorn SH, Rothschild AJ, Snavely D, Ghosh K, Ball WA, Reines SA, Munjack D, Apter JT, Cunningham L, Kling M, Bari M, Getson A, Lee Y (2004) Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression. Neuropsychopharmacology 29:385–392PubMedCrossRefGoogle Scholar
  89. Kreibich AS, Blendy JA (2004) cAMP response element-binding protein is required for stress but not cocaine-induced reinstatement. J Neurosci 24:6686–6692PubMedCrossRefGoogle Scholar
  90. Kupferschmidt DA, Brown ZJ, Erb S (2011) A procedure for studying the footshock-induced reinstatement of cocaine seeking in laboratory rats. J Vis Exp doi:10.3791/2265
  91. Kvetnansky R, Mikulaj L (1970) Adrenal and urinary catecholamines in rats during adaptation to repeated immobilization stress. Endocrinology 87:738–743PubMedCrossRefGoogle Scholar
  92. Lang PJ, Bradley MM, Cuthbert BN (1995) International affective picture system (IAPS): technical manual and affective ratings. The Center for Research in Psychophysiology, University of FloridaGoogle Scholar
  93. Le A, Shaham Y (2002) Neurobiology of relapse to alcohol in rats. Pharmacol Ther 94:137–156PubMedCrossRefGoogle Scholar
  94. Le AD, Poulos CX, Harding S, Watchus W, Juzytsch W, Shaham Y (1999) Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress in rats. Neuropsychopharmacology 21:435–444PubMedCrossRefGoogle Scholar
  95. Le AD, Harding S, Juzytsch W, Watchus J, Shalev U, Shaham Y (2000) The role of corticotropin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology 150:317–324PubMedCrossRefGoogle Scholar
  96. Le AD, Harding S, Juzytsch W, Fletcher PJ, Shaham Y (2002) The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J Neurosci 22:7844–7849PubMedGoogle Scholar
  97. Le AD, Harding S, Juzytsch W, Funk D, Shaham Y (2005) Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology 179:366–373PubMedCrossRefGoogle Scholar
  98. Le AD, Funk D, Harding S, Juzytsch W, Fletcher PJ (2009) The role of noradrenaline and 5-hydroxytryptamine in yohimbine-induced increases in alcohol-seeking in rats. Psychopharmacology 204:477–488CrossRefGoogle Scholar
  99. Lê AD, Funk D, Juzytsch W, Coen K, Navarre BM, Cifani C, Shaham Y (2011) Effects of prazosin and guanfacine on yohimbine-induced reinstatement of alcohol and food seeking in rats. Psychopharmacology (in press)Google Scholar
  100. Lee B, Tiefenbacher S, Platt DM, Spealman RD (2004) Pharmacological blockade of alpha(2)-arenoceptors induces reinstatement of cocaine-seeking behavior in squirrel monkeys. Neuropsychopharmacology 29:686–693PubMedCrossRefGoogle Scholar
  101. Leri F, Flores J, Rodaros D, Stewart J (2002) Blockade of stress-induced, but not cocaine-induced reinstatement, by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J Neurosci 22:5713–5718PubMedGoogle Scholar
  102. Liston C, McEwen BS, Casey BJ (2009) Psychosocial stress reversibly disrupts prefrontal processing and attentional control. Proc Nat Acad Sci USA 106:912–917PubMedCrossRefGoogle Scholar
  103. Liu X, Weiss F (2002) Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci 22:7856–7861PubMedGoogle Scholar
  104. Logothetis NK, Pauls J, Augath M, Trinath T, Oeltermann A (2001) Neurophysiological investigation of the basis of the fMRI signal. Nature 412:150–157PubMedCrossRefGoogle Scholar
  105. Lu L, Shepard JD, Scott Hall F, Shaham Y (2003) Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review. Neurosci Biobehav Rev 27:457–491PubMedCrossRefGoogle Scholar
  106. Lubman DI, Yucel M, Kettle JW, Scaffidi A, Mackenzie T, Simmons JG, Allen NB (2009) Responsiveness to drug cues and natural rewards in opiate addiction: associations with later heroin use. Arch Gen Psychiatry 66:205–212PubMedCrossRefGoogle Scholar
  107. Lynch WJ (2006) Sex differences in vulnerability to drug self-administration. Exp Clin Psychopharmacol 14:34–41PubMedCrossRefGoogle Scholar
  108. Mantsch JR, Goeders NE (1999) Ketoconazole blocks the stress-induced reinstatement of cocaine-seeking behavior in rats: relationship to the discriminative stimulus effects of cocaine. Psychopharmacology 142:399–407PubMedCrossRefGoogle Scholar
  109. Mantsch JR, Baker DA, Francis DM, Katz ES, Hoks MA, Serge JP (2008) Stressor- and corticotropin releasing factor-induced reinstatement and active stress-related behavioral responses are augmented following long-access cocaine self-administration by rats. Psychopharmacology 195:591–603PubMedCrossRefGoogle Scholar
  110. Mantsch JR, Weyer A, Vranjkovic O, Beyer CE, Baker DA, Caretta H (2010) Involvement of noradrenergic neurotransmission in the stress- but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for beta-2 adrenergic receptors. Neuropsychopharmacology 35:2165–2178PubMedCrossRefGoogle Scholar
  111. Mantyh PW, Hunt SP, Maggio JE (1984) Substance P receptors: localization by light microscopic autoradiography in rat-brain using [3H]Sp as the radioligand. Brain Res 307:147–165PubMedCrossRefGoogle Scholar
  112. Marinelli PW, Funk D, Juzytsch W, Harding S, Rice KC, Shaham Y, Le AD (2007) The CRF(1) receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology 195:345–355PubMedCrossRefGoogle Scholar
  113. McFarland K, Davidge SB, Lapish CC, Kalivas PW (2004) Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J Neurosci 24:1551–1560PubMedCrossRefGoogle Scholar
  114. McKee S, Sinha R, Weinberger AH, Sofuoglu M, Harrison EL, Lavery M, Wanzer J (2011) Stress decreases the ability to resist smoking and potentiates smoking intensity and reward. J Psychopharmacol 4:490–502CrossRefGoogle Scholar
  115. Miczek KA, Weerts E, Haney M, Tidey J (1994) Neurobiological mechanisms controlling aggression: preclinical developments for pharmacotherapeutic interventions. Neurosci Biobehav Rev 18:97–110PubMedCrossRefGoogle Scholar
  116. Miczek KA, Yap JJ, Covington HE 3rd (2008) Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake. Pharmacol Ther 120:102–128PubMedCrossRefGoogle Scholar
  117. Mongeau R, Blier P, de Montigny C (1997) The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Rev 23:145–195PubMedCrossRefGoogle Scholar
  118. Monti PM, Rohsenow DJ, Rubonis AV, Niaura RS, Sirota AD, Colby SM, Abrams DB (1993) Alcohol cue reactivity: effects of detoxification and extended exposure. J Stud Alcohol 54:235–245PubMedGoogle Scholar
  119. Nair SG, Adams-Deutsch T, Epstein DH, Shaham Y (2009) The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking. Prog Neurobiol 89:18–45PubMedCrossRefGoogle Scholar
  120. Nair SG, Navarre BM, Cifani C, Pickens CL, Bossert JM, Shaham Y (2011) Role of dorsal medial prefrontal cortex dopamine D1-family receptors in relapse to high-fat food seeking induced by the anxiogenic drug yohimbine. Neuropsychopharmacology 36:497–510PubMedCrossRefGoogle Scholar
  121. Nakaya Y, Kaneko T, Shigemoto R, Nakanishi S, Mizuno N (1994) Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J Comp Neurol 347:249–274PubMedCrossRefGoogle Scholar
  122. Naqvi NH, Bechara A (2009) The hidden island of addiction: the insula. Trends Neurosci 32:56–67PubMedCrossRefGoogle Scholar
  123. Naqvi NH, Rudrauf D, Damasio H, Bechara A (2007) Damage to the insula disrupts addiction to cigarette smoking. Science 315:531–534PubMedCrossRefGoogle Scholar
  124. Nelson EC, Agrawal A, Pergadia ML, Wang JC, Whitfield JB, Saccone FS, Kern J, Grant JD, Schrage AJ, Rice JP, Montgomery GW, Heath AC, Goate AM, Martin NG, Madden PA (2010) H2 haplotype at chromosome 17q21.31 protects against childhood sexual abuse-associated risk for alcohol consumption and dependence. Addict Biol 15:1–11PubMedCrossRefGoogle Scholar
  125. O’Brien CP, Gardner EL (2005) Critical assessment of how to study addiction and its treatment: human and non-human animal models. Pharmacol Ther 108:18–58PubMedCrossRefGoogle Scholar
  126. O’Doherty F, Davies BJ (1987) Life events and addiction: a critical review. Br J Addict 82:127–137PubMedCrossRefGoogle Scholar
  127. Pan JW, Stein DT, Telang F, Lee JH, Shen J, Brown P, Cline G, Mason GF, Shulman GI, Rothman DL, Hetherington HP (2000) Spectroscopic imaging of glutamate C4 turnover in human brain. Magn Reson Med 44:673–679PubMedCrossRefGoogle Scholar
  128. Papp M, Vassout A, Gentsch C (2000) The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats. Behav Brain Res 115:19–23PubMedCrossRefGoogle Scholar
  129. Pavlov IP (1927) Conditioned reflexes. Oxford University Press, UKGoogle Scholar
  130. Payan DG (1989) Neuropeptides and inflammation: the role of substance P. Annu Rev Med 40:341–352PubMedCrossRefGoogle Scholar
  131. Perry W, Minassian A, Paulus MP, Young JW, Kincaid MJ, Ferguson EJ, Henry BL, Zhuang X, Masten VL, Sharp RF, Geyer MA (2009) A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry 66:1072–1780PubMedCrossRefGoogle Scholar
  132. Piazza PV, Le Moal M (1998) The role of stress in drug self-administration. Trends Pharmacol Sci 19:67–74PubMedCrossRefGoogle Scholar
  133. Preston KL, Epstein DH (2011) Stress in the daily lives of cocaine and heroin users: Relationship to mood, craving, relapse triggers, and cocaine use. Psychopharmacology (in press)Google Scholar
  134. Redila VA, Chavkin C (2008) Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system. Psychopharmacology 200:59–70PubMedCrossRefGoogle Scholar
  135. Redmond DEJ, Huang YH (1979) Locus coeruleus and anxiety. Life Sci 25:2149–2162PubMedCrossRefGoogle Scholar
  136. Ribeiro Do Couto B, Aguilar MA, Manzanedo C, Rodriguez-Arias M, Armario A, Minarro J (2006) Social stress is as effective as physical stress in reinstating morphine-induced place preference in mice. Psychopharmacology 185:459–470PubMedCrossRefGoogle Scholar
  137. Rodaros D, Caruana DA, Amir S, Stewart J (2007) Corticotropin-releasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area. Neuroscience 150:8–13PubMedCrossRefGoogle Scholar
  138. Rupniak NM, Carlson EC, Harrison T, Oates B, Seward E, Owen S, De Felipe C, Hunt S, Wheeldon A (2000) Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice. Neuropharmacology 39:1413–1421PubMedCrossRefGoogle Scholar
  139. Rupniak NMJ, Carlson EJ, Webb JK, Harrison T, Porsolt RD, Roux S, De Felipe C, Hunt SP, Oates B, Wheeldon A (2001) Comparison of the phenotype of NK1R−/− mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs. Behav Pharmacol 12:497–508PubMedCrossRefGoogle Scholar
  140. Sallee FR, Eaton K (2010) Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD). Expert Opin Pharmacother 11:2549–2556PubMedCrossRefGoogle Scholar
  141. Sanchez CJ, Sorg BA (2001) Conditioned fear stimuli reinstate cocaine-induced conditioned place preference. Brain Res 908:86–92PubMedCrossRefGoogle Scholar
  142. Sanchez CJ, Bailie TM, Wu WR, Li N, Sorg BA (2003) Manipulation of dopamine d1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior. Neuroscience 119:497–505PubMedCrossRefGoogle Scholar
  143. Santarelli L, Gobbi G, Debs PC, Sibille ET, Blier P, Hen R, Heath MJ (2001) Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci USA 98:1912–1917PubMedCrossRefGoogle Scholar
  144. Sawchenko PE, Li HY, Ericsson A (2000) Circuits and mechanisms governing hypothalamic responses to stress: a tale of two paradigms. Prog Brain Res 122:61–78PubMedCrossRefGoogle Scholar
  145. Schank JR, Pickens CL, Rowe KE, Cheng K, Thorsell A, Rice KC, Shaham Y, Heilig M (2011) Stress-induced reinstatement of alcohol seeking in rats is selectively suppressed by the neurokinin 1 (NK1) antagonist L822429. Psychopharmacology (in press)Google Scholar
  146. Scriabine A, Sweet CS, Ludde CT, Stavorski JM, Wenger HC, Bohidar NR (1975) Some cardiovascular effects of ST-91 and clonidine. Eur J Pharmacol 43:333–341CrossRefGoogle Scholar
  147. See RE (2005) Neural substrates of cocaine-cue associations that trigger relapse. Eur J Pharmacol 526:140–146PubMedCrossRefGoogle Scholar
  148. See RE, Waters RP (2010) Pharmacologically-induced stress: a cross-species probe for translational research in drug addiction and relapse. Am J Transl Res 3:81–89PubMedGoogle Scholar
  149. Selye H (1956) The stress of life. McGraw-Hill, New YorkGoogle Scholar
  150. Seo D, Sinha R (2011) Neuroimaging stress in addiction. In: Adinoff B, Stein E (eds) Neuroimaging and addiction. Wiley and Sons (in press)Google Scholar
  151. Seo D, Jia Z, Lacadie C, Tsou K, Bergquist K, Sinha R (2011) Sex differences in neural response to stress and alcohol context cues. Human Brain Mapping (in press)Google Scholar
  152. Shaham Y (1996) Effect of stress on opioid-seeking behavior: evidence from studies with rats. Ann Behav Med 18:255–263PubMedCrossRefGoogle Scholar
  153. Shaham Y, Stewart J (1995) Stress reinstates heroin self-administration behavior in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology 119:334–341PubMedCrossRefGoogle Scholar
  154. Shaham Y, Stewart J (1996) Effects of opioid and dopamine receptor antagonists on relapse induced by stress and reexposure to heroin in rats. Psychopharmacology 125:385–391PubMedCrossRefGoogle Scholar
  155. Shaham Y, Funk D, Erb S, Brown TJ, Walker CD, Stewart J (1997) Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci 17:2605–2614PubMedGoogle Scholar
  156. Shaham Y, Erb S, Stewart J (2000a) Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Brain Res Rev 33:13–33PubMedCrossRefGoogle Scholar
  157. Shaham Y, Highfield D, Delfs JM, Leung S, Stewart J (2000b) Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of the locus coeruleus noradrenergic neurons. Eur J Neurosci 12:292–302PubMedCrossRefGoogle Scholar
  158. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 168:3–20PubMedCrossRefGoogle Scholar
  159. Shalev U, Highfield D, Yap J, Shaham Y (2000) Stress and relapse to drug seeking in rats: studies on the generality of the effect. Psychopharmacology 150:337–346PubMedCrossRefGoogle Scholar
  160. Shalev U, Morales M, Hope B, Yap J, Shaham Y (2001a) Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats. Psychopharmacology 156:98–107PubMedCrossRefGoogle Scholar
  161. Shalev U, Yap J, Shaham Y (2001b) Leptin attenuates food deprivation-induced relapse to heroin seeking. J Neurosci 21:RC129PubMedGoogle Scholar
  162. Shalev U, Grimm JW, Shaham Y (2002) Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54:1–42PubMedCrossRefGoogle Scholar
  163. Shalev U, Erb S, Shaham Y (2010) Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res 1314:15–28PubMedCrossRefGoogle Scholar
  164. Shepard JD, Bossert JM, Liu SY, Shaham Y (2004) The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse. Biol Psychiatry 55:1082–1089PubMedCrossRefGoogle Scholar
  165. Shiffman S (2005) Dynamic influences on smoking relapse process. J Pers 73:1715–1748PubMedCrossRefGoogle Scholar
  166. Shiffman S, Waters AJ (2004) Negative affect and smoking lapses: a prospective analysis. J Consult Clin Psychol 72:192–201PubMedCrossRefGoogle Scholar
  167. Shiffman S, Paty JA, Gnys M, Kassel JA, Hickcox M (1996) First lapses to smoking: within-subjects analysis of real-time reports. J Consult Clin Psychol 64:366–379PubMedCrossRefGoogle Scholar
  168. Shiffman S, Waters A, Hickcox M (2004) The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res 6:327–348PubMedCrossRefGoogle Scholar
  169. Shors TJ (2006) Stressful experience and learning across the lifespan. Annu Rev Psychol 57:55–85PubMedCrossRefGoogle Scholar
  170. Sibson NR, Dhankhar A, Mason GF, Rothman DL, Behar KL, Shulman RG (1998) Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci USA 95:316–321PubMedCrossRefGoogle Scholar
  171. Singewald N, Chicchi GG, Thurner CC, Tsao KL, Spetea M, Schmidhammer H, Sreepathi HK, Ferraguti F, Singewald GM, Ebner K (2008) Modulation of basal and stress-induced amygdaloid substance P release by the potent and selective NK1 receptor antagonist L-822429. J Neurochem 106:2476–2488PubMedCrossRefGoogle Scholar
  172. Sinha R (2001) How does stress increase risk of drug abuse and relapse. Psychopharmacology 158:343–359PubMedCrossRefGoogle Scholar
  173. Sinha R (2009) Modeling stress and drug craving in the laboratory: implications for addiction treatment development. Addict Biol 14:84–98PubMedCrossRefGoogle Scholar
  174. Sinha R, Catapano D, O’Mally S (1999) Stress-induced craving and stress responses in cocaine dependent individuals. Psychopharmacology 142:343–351PubMedCrossRefGoogle Scholar
  175. Sinha R, Fuse T, Aubin LR, O’Malley SS (2000) Psychological stress, drug-related cues and cocaine craving. Psychopharmacology 152:140–148PubMedCrossRefGoogle Scholar
  176. Sinha R, Lacadie C, Skudlarski P, Fulbright RK, Kosten TR, Rounsaville BJ, Wexler BE (2004) Neural activity associated with stress-induced cocaine craving: an fMRI study. Annal N Y Acad Sci 1032:254–257CrossRefGoogle Scholar
  177. Sinha R, Lacadie C, Skudlarski P, Fulbright RK, Rounsaville BJ, Kosten TR, Wexler BE (2005) Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging study. Psychopharmacology 183:171–180PubMedCrossRefGoogle Scholar
  178. Sinha R, Garcia M, Paliwal P, Kreek MJ, Rounsaville BJ (2006) Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 63:324–331PubMedCrossRefGoogle Scholar
  179. Sinha R, Kimmerling A, Doebrick C, Kosten TR (2007) Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings. Psychopharmacology 190:569–574PubMedCrossRefGoogle Scholar
  180. Sinha R, Fox HC, Hong KI, Siedlarz K, Tuit K, Kreek MJ (2011a) Effects of adrenal sensitivity, stress and cue induced alcohol craving and anxiety on subsequent relapse and treatment outcomes. Archives of General Psychiatry (in press)Google Scholar
  181. Sinha R, Hong KA, Seo D, Fox H, Bergquist K (2011b) Neural and endocrine predictions of alcohol relapse risk. Alcoholism: Clin Exp Res (in press)Google Scholar
  182. Skinner BF (1938) The behavior of organisms. Appleton-Century-Crofts, Appleton-Century-CroftsGoogle Scholar
  183. Sommer WH, Rimondini R, Hansson AC, Hipskind PA, Gehlert DR, Barr CS, Heilig M (2008) Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence. Biol Psychiatry 63:139–145PubMedCrossRefGoogle Scholar
  184. Soufer R, Bremner JD, Arrighi JA, Cohen I, Zaret BL, Burg MM, Goldman-Rakic P (1998) Cerebral cortical hyperactivation in response to mental stress in patients with coronary artery disease. Proc Natl Acad Sci USA 95:6454–6459PubMedCrossRefGoogle Scholar
  185. Specio SE, Wee S, O’Dell LE, Boutrel B, Zorrilla EP, Koob GF (2008) CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats. Psychopharmacology 196:473–482PubMedCrossRefGoogle Scholar
  186. Stanford SC (1995) Central noradrenergic neurones and stress. Pharmacol Ther 68:297–342PubMedCrossRefGoogle Scholar
  187. Stine SM, Southwick SM, Petrakis IL, Kosten TR, Charney DS, Krystal JH (2002) Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biol Psychiatry 51:642–651PubMedCrossRefGoogle Scholar
  188. Tanaka M, Tsuda A, Yokoo H, Yoshida M, Yoshishige I, Nishimura H (1990) Involvement of the brain noradrenaline system in emotional changes caused by stress in rats. Annal N Y Acad Sci 597:159–174CrossRefGoogle Scholar
  189. Teixeira RM, Santos AR, Ribeiro SJ, Calixto JB, Rae GA, De Lima TC (1996) Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. Eur J Pharmacol 311:7–14PubMedCrossRefGoogle Scholar
  190. Treutlein J, Kissling C, Frank J, Wiemann S, Dong L, Depner M, Saam C, Lascorz J, Soyka M, Preuss UW, Rujescu D, Skowronek MH, Rietschel M, Spanagel R, Heinz A, Laucht M, Mann K, Schumann G (2006) Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry 11:594–602PubMedCrossRefGoogle Scholar
  191. Umhau JC, Schwandt ML, Usala J, Geyer C, Singley E, George TD, Heilig M (2011) Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate. Neuropsychopharmacology 60:303–311Google Scholar
  192. Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213:1394–1397PubMedCrossRefGoogle Scholar
  193. Van Loon GR, Kvetnansky R, McCarty R, Axelrod J (1989) Stress: neurochemical and humoral mechanisms. Gordon & Breach, New YorkGoogle Scholar
  194. Varty GB, Cohen-Williams ME, Morgan CA, Pylak U, Duffy RA, Lachowicz JE, Carey GJ, Coffin VL (2002) The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists. Neuropsychopharmacology 27:371–379PubMedCrossRefGoogle Scholar
  195. Voorn P, Vanderschuren LJ, Groenewegen HJ, Robbins TW, Pennartz CM (2004) Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci 27:468–474PubMedCrossRefGoogle Scholar
  196. Wang X, Cen X, Lu L (2001) Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats. Eur J Pharmacol 432:153–161PubMedCrossRefGoogle Scholar
  197. Wang B, Luo F, Ge XC, Fu AH, Han JS (2002) Effects of lesions of various brain areas on drug priming or footshock-induced reactivation of extinguished conditioned place preference. Brain Res 950:1–9PubMedCrossRefGoogle Scholar
  198. Wang B, Shaham Y, Zitzman D, Azari S, Wise RA, You ZB (2005) Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J Neurosci 25:5389–5396PubMedCrossRefGoogle Scholar
  199. Wang J, Fang Q, Liu Z, Lu L (2006) Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats. Psychopharmacology 185:19–28PubMedCrossRefGoogle Scholar
  200. Wang B, You ZB, Rice KC, Wise RA (2007) Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat. Psychopharmacology 193:283–294PubMedCrossRefGoogle Scholar
  201. Wikler A (1973) Dynamics of drug dependence, implication of a conditioning theory for research and treatment. Arch Gen Psychiatry 28:611–616PubMedGoogle Scholar
  202. Xi ZX, Gilbert J, Campos AC, Kline N, Ashby CR Jr, Hagan JJ, Heidbreder CA, Gardner EL (2004) Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats. Psychopharmacology 176:57–65PubMedCrossRefGoogle Scholar
  203. Yamada H, Bruijnzeel AW (2011) Stimulation of alpha2-adrenergic receptors in the central nucleus of the amygdala attenuates stress-induced reinstatement of nicotine seeking in rats. Neuropharmacology 60:303–311PubMedCrossRefGoogle Scholar
  204. Zislis G, Desai TV, Prado M, Shah HP, Bruijnzeel AW (2007) Effects of the CRF receptor antagonist D-Phe CRF(12–41) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats. Neuropharmacology 53:958–966PubMedCrossRefGoogle Scholar
  205. Zorrilla EP, Koob GF (2010) Progress in corticotropin-releasing factor-1 antagonist development. Drug Discov Today 15:371–383PubMedCrossRefGoogle Scholar
  206. Zorrilla EP, Valdez GR, Weiss F (2001) Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology 158:374–381PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag (outside the USA) 2011

Authors and Affiliations

  1. 1.Department of PsychiatryYale UniversityNew HavenUSA
  2. 2.Behavioral Neuroscience BranchIRP/NIDA/NIH/DHHSBaltimoreUSA
  3. 3.Laboratory of Clinical and Translational StudiesIRP/NIAAA/NIH/DHHSBethesdaUSA

Personalised recommendations